doi:10.3390/biomedicines12091943 Bliddal H, Bays H, Czernichow S, et al
Microalgae: a potential alternative to health supplementation for humans
GLP-1s remain life-changing even life-saving for millions of people
One study found that weekly treatment with semaglutide, a GLP-1 RA, reduced the risk of a combination of stroke, heart attack, and death from cardiovascular causes by 20% compared with placebo.
IGF-1 LR3 (Long R3 IGF-1, CAS 946870-92-4) is a recombinant 83-amino-acid analogue of insulin-like growth factor 1 with an N-terminal extension and Arg3 substitution, extending plasma half-life and reducing IGFBP binding
Stay Hydrated: Drink small sips of water or electrolyte drinks